These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19654513)

  • 1. Nepafenac-associated bilateral corneal melt after photorefractive keratectomy.
    Feiz V; Oberg TJ; Kurz CJ; Mamalis N; Moshirfar M
    Cornea; 2009 Sep; 28(8):948-50. PubMed ID: 19654513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case of corneal melting associated with the use of topical nepafenac.
    Bekendam PD; Narváez J; Agarwal M
    Cornea; 2007 Sep; 26(8):1002-3. PubMed ID: 17721306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of topical nepafenac on corneal epithelial healing time and postoperative pain after PRK: a bilateral, prospective, randomized, masked trial.
    Caldwell M; Reilly C
    J Refract Surg; 2008 Apr; 24(4):377-82. PubMed ID: 18500088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nepafenac sodium 0.1% on delayed corneal epithelial healing and haze after photorefractive keratectomy: retrospective comparative study.
    Jalali S; Yuen LH; Boxer Wachler BS
    J Cataract Refract Surg; 2008 Sep; 34(9):1542-5. PubMed ID: 18721717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
    Trattler W; McDonald M
    Cornea; 2007 Jul; 26(6):665-9. PubMed ID: 17592313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corneal melting after use of nepafenac in a patient with chronic cystoid macular edema after cataract surgery.
    Di Pascuale MA; Whitson JT; Mootha VV
    Eye Contact Lens; 2008 Mar; 34(2):129-30. PubMed ID: 18327052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: a phase II, randomized, double-masked trial.
    Colin J; Paquette B
    Clin Ther; 2006 Apr; 28(4):527-36. PubMed ID: 16750464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal ulceration and perforation with ketorolac tromethamine.
    Lee WB; Himmel K
    Cornea; 2006 Dec; 25(10):1268. PubMed ID: 17172920
    [No Abstract]   [Full Text] [Related]  

  • 9. Double-masked study of the effects of nepafenac 0.1% and ketorolac 0.4% on corneal epithelial wound healing and pain after photorefractive keratectomy.
    Donnenfeld ED; Holland EJ; Durrie DS; Raizman MB
    Adv Ther; 2007; 24(4):852-62. PubMed ID: 17901034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery.
    Maxwell WA; Reiser HJ; Stewart RH; Cavanagh HD; Walters TR; Sager DP; Meuse PA
    J Ocul Pharmacol Ther; 2008 Dec; 24(6):593-9. PubMed ID: 19040348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nepafenac-associated corneal melt.
    Wolf EJ; Kleiman LZ; Schrier A
    J Cataract Refract Surg; 2007 Nov; 33(11):1974-5. PubMed ID: 17964407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
    Duong HV; Westfield KC; Chalkley TH
    J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal ulceration and perforation with ketorolac tromethamine (Acular) use after PRK.
    Mian SI; Gupta A; Pineda R
    Cornea; 2006 Feb; 25(2):232-4. PubMed ID: 16371790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late corneal perforation after photorefractive keratectomy associated with topical diclofenac: involvement of matrix metalloproteinases.
    Gabison EE; Chastang P; Menashi S; Mourah S; Doan S; Oster M; Mauviel A; Hoang-Xuan T
    Ophthalmology; 2003 Aug; 110(8):1626-31. PubMed ID: 12917183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK).
    Durrie DS; Kennard MG; Boghossian AJ
    Adv Ther; 2007; 24(6):1278-85. PubMed ID: 18165210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
    Almeida DR; Khan Z; Xing L; Bakar SN; Rahim K; Urton T; El-Defrawy SR
    J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
    Lindstrom R; Holland E; Lane S; Raizman M; Reilly C
    Cornea; 2008 Apr; 27(3):385-6; author reply 386-7. PubMed ID: 18362679
    [No Abstract]   [Full Text] [Related]  

  • 18. Ketorolac versus nepafenac in cataract surgery.
    McCulley JP
    J Cataract Refract Surg; 2008 Mar; 34(3):345-6; author reply 346. PubMed ID: 18299048
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the Tolerability of Diclofenac and Nepafenac.
    Achiron A; Karmona L; Mimouni M; Gershoni A; Dzhanov Y; Gur Z; Burgansky Z
    J Ocul Pharmacol Ther; 2016 Nov; 32(9):601-605. PubMed ID: 27513223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
    Toyos R
    Cornea; 2008 Apr; 27(3):384; author reply 384-5. PubMed ID: 18362678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.